NCT04787679

Brief Summary

Due to the increase in the average age of the population, the projections on the number of age-dependent bone fractures appear to be constantly increasing. They are mainly due to bone pathologies, including osteoporosis. The latter leads to a reduction in bone mineral density and deterioration of the micro-architecture, with a consequent increase in bone fragility. However, the mechanisms of damage at the micro-scale have not yet been elucidated and there is no universally recognized damage criterion. Recent research has evaluated the importance of implementing computational models to study the influence of bone gaps, canaliculi and microporosities on the propagation of damage. These models need to be validated through experimental tests, still lacking, in particular on human bones, in the current scientific landscape. Once the experimental validation of computational models has been developed, it will be possible to introduce new fracture indices at the micro-scale, useful for a preventive diagnosis of osteoporosis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
27mo left

Started Nov 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Nov 2020Aug 2028

Study Start

First participant enrolled

November 9, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2026

Expected
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 9, 2028

Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

5.7 years

First QC Date

March 1, 2021

Last Update Submit

January 27, 2026

Conditions

Keywords

lacunaedamage modelsmicro-crackssynchrotronnumerical models

Outcome Measures

Primary Outcomes (1)

  • Number of lacunae interested by damage

    We expect to observe difference in osteoporotic and non osteoporotic samples interested or not by the damage

    six months

Study Arms (2)

Osteoporotic patients

Osteoporotic patients, age \> 18 years old

Procedure: Hip replacement surgery

Non osteoporotic patients

Non osteoporotic patients, age \> 18 years old

Procedure: Hip replacement surgery

Interventions

After hip replacement surgery the sponsor obtains femoral head samples for the study

Non osteoporotic patientsOsteoporotic patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The population consists of 52 subjects, 26 of whom are prosthetic and have osteoporosis detectable by preoperative computed tomography (CT) scan and 26 prosthetic whose CT scan does not indicate the presence of osteoporosis. The classification of the two groups will be made exclusively by analysis of routine preoperative CT scans according to standard radiological classification.

You may qualify if:

  • Age: \>=18 years
  • primary hip replacement
  • Signature of informed consent
  • Patients who have a routine preoperative CT scan

You may not qualify if:

  • Bone disease (non-osteoporotic) such as to invalidate sample analysis, including but not limited to genetic disorders and bone tumors
  • Patients with contralateral hip replacement and/or other synthetic means in the contralateral hip
  • Patients with synthesis devices in the hip of interest

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Ortopedico Galeazzi

Miano, Milano, 20161, Italy

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Waste materials from human femoral heads collected after hip replacement surgery

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Luigi Zagra

    IRCCS Istituto Ortopedico Galeazzi

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Federica Buccino

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 1, 2021

First Posted

March 9, 2021

Study Start

November 9, 2020

Primary Completion (Estimated)

July 9, 2026

Study Completion (Estimated)

August 9, 2028

Last Updated

January 29, 2026

Record last verified: 2026-01

Locations